Sarepta Therapeutics, Inc.SRPTNASDAQ
LOADING
|||
Business Scale
Growth Engine
Valuation Context
Market Cap
$2.1B
Mid Cap
P/E (TTM)
N/A
—
P/S (TTM)
0.9x
Discounted
EV/EBITDA
N/A
—
A mid-sized company, with solid profitability, with revenues declining trading at a discount.
Explore metrics